Angiotensin-(1-7) and Its Role in Heart Health and Obesity
Author Information
Author(s): Vernail Victoria L., Lucas Lillia, Miller Amanda J., Arnold Amy C., Hosohata Keiko
Primary Institution: Pennsylvania State University College of Medicine
Hypothesis
Targeting the protective angiotensin-(1-7) axis may improve cardiovascular and metabolic functions in obesity-related hypertension.
Conclusion
Angiotensin-(1-7) shows potential as a novel therapeutic approach for managing obesity-related hypertension by improving cardiovascular and metabolic outcomes.
Supporting Evidence
- Hypertension is a major risk factor for cardiovascular disease, which is often linked to obesity.
- Current antihypertensive therapies have limited efficacy and can cause adverse effects.
- Angiotensin-(1-7) has shown positive effects on blood pressure and metabolic health in animal models.
Takeaway
This study looks at a hormone called angiotensin-(1-7) that might help people with high blood pressure and obesity feel better and healthier.
Methodology
This is a review article summarizing various studies on angiotensin-(1-7) and its effects on cardiovascular and metabolic functions.
Limitations
The review primarily focuses on animal studies, and the translation of findings to human populations is still under investigation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website